A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources

Kamlesh Gidwani, Kaisa Huhtinen, Henna Kekki, Sandra van Vliet, Johanna Hynninen, Niina Koivuviita, Anti Perheentupa, Matti Poutanen, Annika Auranen, Seija Grenman, Urpo Lamminmaki, Olli Carpen, Yvette van Kooyk, Kim Pettersson

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalClinical Chemistry (Washington, DC)
Volume62
Issue number10
Pages (from-to)1390-1400
Number of pages11
ISSN0009-9147
DOIs
Publication statusPublished - Oct 2016
MoE publication typeA1 Journal article-refereed

Fields of Science

  • COLON-CANCER PATIENTS
  • OVARIAN-CANCER
  • GLYCOSYLATION
  • IDENTIFICATION
  • RECOGNITION
  • ANTIGENS
  • RECEPTOR
  • GLYCANS
  • GLYCOME
  • BINDING
  • 217 Medical engineering
  • 3111 Biomedicine

Cite this